LUNG DISEASE MEDICATIONS
150 mg NOXALK Ceritinib Capsules
Price on Request
NOXALK 150 mg capsules (Ceritinib) are an oral, targeted kinase inhibitor manufactured by Natco Pharma. They are primarily used to treat adults with advanced or metastatic ALK-positive non-small cell lung cancer (NSCLC) who have progressed on or cannot tolerate crizotinib.
liketo.usa,uk,china,southkorea,russia,japan,singapore
liketo.usa,uk,china,southkorea,russia,japan,singapore
Composition
Strength 150 mg
Pack Size 90 capsules
Brand NOXALK
Company Natco
Usage Lung cancer, NSCLC
Shelf Life 24 months
Packaging Size 90 capsules
Brand Name Noxalk
Manufacturer Natco
Packaging Type Bottle
Product Form Capsules
Composition Ceritinib Capsules IP
Minimum order quantity: 50 Box
Enquire About This Product
